Questions to Mead et al. on making interpretive uncertainty visible in clinical flow cytometry
Cytometry Part B: Clinical Cytometry · 14.11.2026
DOI: 10.1002/cyto.b.70094 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cytometry Part B: Clinical Cytometry, online erschienen am 14.11.2026. Verfasst von Marc Sorigue und 1 weiteren Autor:innen. Beteiligte Einrichtung: Functional Cytomics Lab, Germans Trias i Pujol Research Institute (IGTP), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Bada…. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
We read with interest the recent article by Mead et al. (2026) on interpretive contributions to analytical variability in clinical flow cytometry.The authors use a thoughtful design: a low-complexity T-cell, B-cell, and natural killer (TBNK) assay, a large clinical dataset, multiple technologists, and, importantly, an invariant automated workflow used as an analytical reference rather than as biological ground truth.
Autor:innen und Institutionen
- Functional Cytomics Lab, Germans Trias i Pujol Research Institute (IGTP), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.
ORCID-Profile: Marc Sorigue
Zitieren
APA
Sorigue, M., & Petriz, J. (2026). Questions to Mead et al. on making interpretive uncertainty visible in clinical flow cytometry. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.70094
Vancouver
Sorigue M, Petriz J. Questions to Mead et al. on making interpretive uncertainty visible in clinical flow cytometry. Cytometry Part B: Clinical Cytometry. 2026. doi:10.1002/cyto.b.70094
BibTeX
@article{Sorigue2026,
author = {Sorigue, Marc and Petriz, Jordi},
title = {Questions to Mead et al. on making interpretive uncertainty visible in clinical flow cytometry},
journal = {Cytometry Part B: Clinical Cytometry},
year = {2026},
doi = {10.1002/cyto.b.70094}
}
EUVIMED